BioSpace News Archive

Genetown

Talaris Therapeutics Announces Upcoming Presentations at American Society of Nephrology Annual Meeting

Talaris Therapeutics, Inc. today announced upcoming data presentations at the American Society of Nephrology (ASN) Annual Meeting, taking place November 3-6, 2022 in Orlando, Fla.

October 17, 2022
·
4 min read
FDA

Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease

Mereo BioPharma Group plc today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its investigational oral neutrophil elastase inhibitor, alvelestat (MPH-966).

October 17, 2022
·
6 min read
Pharm Country

Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at the National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit

Zynerba Pharmaceuticals, Inc. presented a poster at the 2022 National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit being held October 17-18, 2022, in Washington, D.C.

October 17, 2022
·
6 min read
Galapagos to host its R&D Update 2022 in New York on 4 November 2022

Galapagos NV announced that it will host its R&D Day 2022 for analysts, investors and financial press on Friday, 4 November2022.

October 17, 2022
·
2 min read
Business

Pharnext Reports First Half 2022 Financial Results

Pharnext SA, an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, announces its financial results for the first half of 2022.

October 17, 2022
·
8 min read
Policy

Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan

Alvotech announced that its commercialization partner Fuji Pharma Co., Ltd. has submitted an application to the Japanese Ministry of Health, Labor and Welfare for marketing approval of the first biosimilar candidate developed under the companies’ exclusive commercialization partnership.

October 17, 2022
·
7 min read
Business

Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14

Rockwell Medical, Inc. announced that it will release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022.

October 17, 2022
·
1 min read
Biotech Bay

Vivani Medical to Present at the ThinkEquity Investor Conference

Vivani Medical, Inc. announced that it will present at the upcoming ThinkEquity investor conference at 11:00 am EDT at the Mandarin Oriental in New York on October 26, 2022.

October 17, 2022
·
4 min read
BioForest

Kineta Announces Clinical Collaboration with Merck to Evaluate KVA12123 in Combination with KEYTRUDA® (pembrolizumab) in Cancer Patients with Advanced Solid Tumors

Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced that it has entered into a clinical trial collaboration and supply agreement with Merck.

October 17, 2022
·
6 min read
Drug Development

Nuvalent to Host Conference Call to Discuss Preliminary Phase 1 Data from ARROS-1 Clinical Trial of NVL-520 and Additional Preclinical Updates in Conjunction with 34th EORTC-NCI-AACR Symposium

Nuvalent, Inc. announced that management will host a live webcast and conference call in conjunction with its data presentations at the 34th EORTC-NCI-AACR Symposium in Barcelona, Spain on Friday, October 28, 2022 at 8:30 a.m. EDT.

October 17, 2022
·
1 min read